Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
Shin Hye Yoo, Chan-Young Ock, Bhumsuk Keam, Sung Joon Park, Tae Min Kim, Jin Ho Kim, Yoon Kyung Jeon, Eun-Jae Chung, Seong Keun Kwon, J. Hun Hah, Tack-Kyun Kwon, Kyeong Chun Jung, Dong-Wan Kim, Hong-Gyun Wu, Myung-Whun Sung, Dae Seog Heo
Korean J Intern Med. 2019;34(6):1313-1323. Published online 2018 Nov 16 DOI: https://doi.org/10.3904/kjim.2017.397
Citations to this article as recorded by 
GAiN: An integrative tool utilizing generative adversarial neural networks for augmented gene expression analysis
Michael R. Waters, Matthew Inkman, Kay Jayachandran, Roman O. Kowalchuk, Clifford Robinson, Julie K. Schwarz, S. Joshua Swamidass, Obi L. Griffith, Jeffrey J. Szymanski, Jin Zhang
Patterns.2024; 5(2): 100910. CrossRef
Clinical prognostic factors to guide treatment strategy for HPV‑positive oropharyngeal cancer using treatment outcomes of induction chemotherapy: A real‑world experience
Hyun Bang, Hyeon-Jong Kim, Seung Lee, Hyun Shim, Jun Hwang, Woo Bae, Ik-Joo Chung, Sang-Hee Cho
Oncology Letters.2024;[Epub] CrossRef
Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes
Michael T Wotman, Tara Ivic-Pavlicic, William H Westra, Brandon Gold, Megan D’Andrea, Eric M Genden, Krzysztof Misiukiewicz, Scott A Roof, Emanuela Taioli, Marshall Posner
The Oncologist.2024; 29(11): 966. CrossRef
Practical Application of Circulating Tumor-Related DNA of Human Papillomavirus in Liquid Biopsy to Evaluate the Molecular Response in Patients with Oropharyngeal Cancer
Agnieszka M. Mazurek, Tomasz W. Rutkowski
Cancers.2023; 15(4): 1047. CrossRef
Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer
Yanyun Ma, Chunxia Wang, Mengqi Shi, Mingshan Li, Lin Li, Tuanjie Che, Jing Qu
Molecular and Clinical Oncology.2022;[Epub] CrossRef
Risk Factors for the Development of Malignant Tumors of the Head and Neck
E. N. Belyakova
Epidemiology and Vaccinal Prevention.2021; 20(1): 92. CrossRef
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era
Andrea Botticelli, Giulia Pomati, Alessio Cirillo, Giulia Mammone, Fabio Ciurluini, Bruna Cerbelli, Paolo Sciattella, Massimo Ralli, Umberto Romeo, Francesca De Felice, Carlo Catalano, Francesco Vullo, Marco Della Monaca, Sasan Amirhassankhani, Silverio T
Journal of Translational Medicine.2021;[Epub] CrossRef
Molecular and clinical aspects of oropharyngeal squamous cell carcinoma associated with human papillomavirus
D. Sh. Polatova, A. Yu. Madaminov
Head and Neck Tumors (HNT).2021; 11(2): 31. CrossRef
A proposal for risk‐based and strategy‐adapted de‐escalation in human papillomavirus‐positive oropharyngeal squamous cell carcinoma
Michael T. Wotman, Brett A. Miles, Richard L. Bakst, Marshall R. Posner
Cancer.2021; 127(23): 4330. CrossRef
Active HPV infection and its influence on survival in head and neck squamous-cell cancer
Anna Janecka-Widła, Anna Mucha-Małecka, Kaja Majchrzyk, Krzysztof Halaszka, Marcin Przewoźnik, Dorota Słonina, Beata Biesaga
Journal of Cancer Research and Clinical Oncology.2020; 146(7): 1677. CrossRef
Oropharyngeal Squamous Cell Carcinoma in 390 Patients: Analysis of Clinical and Histological Criteria Which Significantly Impact Outcome
Lester D. R. Thompson, Raoul Burchette, Shawn Iganej, Onita Bhattasali
Head and Neck Pathology.2019;[Epub] CrossRef